CLINICAL TRIALS

Patients and volunteer trials by expert clinicians.

Trials are a therapeutic hope for many patients. Among other positive aspects of participating in clinical trials, in addition to the opportunity for access to new therapies, there are the altruistic desire to help future patients, increased medical care, financial compensation and greater access to health professionals and medical information.

Code – Name
EC 263CS201 2020/048 – EUDRACT 2018-003825-27 – TALLY

A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

More Information

Code – Name
EC CLOZ-AID 2020/215 – EUDRACT 2020-000091-37

Randomized, multicenter clinical trial to evaluate the safety and tolerability of Clozapine vs. standard clinical practice treatment in adolescents and young adults with treatment-resistant psychosis and intellectual disabilities.

More information

Code – Name
AEMPS UMO-CLO-2019-02. CLOZIN New Users

Phenomics & Genomics of Clozapine Pharmacotherapy- Current Users.(CLOZIN)

MORE INFORMATION

Code – Name
AEMPS UMO-CLO-2019-01. CLOZIN Current Users

Phenomics & Genomics of Clozapine Pharmacotherapy- New Users.(CLOZIN)

More Information

Code – Name
PI19/00236. NCT04343703. SURVIVE

Suicide Prevention and Intervention (SURVIVE): cohort study and nested controlled clinical trials of secondary prevention programs for suicide attempts.

More Information

Code – Name
1402-0012

Phase II randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of 4 oral doses of BI1358894 once daily over a 12-week treatment period in patients with borderline personality disorder.

Learn More

Code – Name
EC CL09-ORY-2001 – EudraCT 2021-000350-26 – EVOLUTION

A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia

More Information

Code – Name
EudraCT Number 2021–001333–38 – CAVES

Cognitive effects of adjuvant vortioxetine in early schizophrenia

More Information

CLINICAL TRIALS

Patients and volunteer trials by expert clinicians.

Code – Name EC 263CS201 2020/048 – EUDRACT 2018-003825-27 – TALLY

A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Code – Name EC CLOZ-AID 2020/215 – EUDRACT 2020-000091-37

Randomized, multicenter clinical trial to evaluate the safety and tolerability of Clozapine vs. standard clinical practice treatment in adolescents and young adults with treatment-resistant psychosis and intellectual disabilities.

Code – NameAEMPS UMO-CLO-2019-02. CLOZIN New Users

Phenomics & Genomics of Clozapine Pharmacotherapy- Current Users.(CLOZIN)

Code – NameAEMPS UMO-CLO-2019-01. CLOZIN Current Users

Phenomics & Genomics of Clozapine Pharmacotherapy- New Users.(CLOZIN)

Code – NamePI19/00236. NCT04343703. SURVIVE

Suicide Prevention and Intervention (SURVIVE): cohort study and nested controlled clinical trials of secondary prevention programs for suicide attempts.

Code – Name1402-0012

Phase II randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of 4 oral doses of BI1358894 once daily over a 12-week treatment period in patients with borderline personality disorder.

Code – Name EC CL09-ORY-2001 – EudraCT 2021-000350-26 – EVOLUTION

A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia

Code – Name EudraCT Number 2021–001333–38 – CAVES

Cognitive effects of adjuvant vortioxetine in early schizophrenia

Code – Name
EC 263CS201 2020/048 – EUDRACT 2018-003825-27 – TALLY

Code – Name
EC CLOZ-AID 2020/215 – EUDRACT 2020-000091-37

Code – Name
AEMPS UMO-CLO-2019-02. CLOZIN New Users

Code – Name
AEMPS UMO-CLO-2019-01. CLOZIN Current Users

Code – Name
PI19/00236. NCT04343703. SURVIVE

Code – Name
1402-0012

Code – Name
EC CL09-ORY-2001 – EudraCT 2021-000350-26 – EVOLUTION

Code – Name
EudraCT Number 2021–001333–38 – CAVES